Insider Shareholders with Direct Ownership of Biogen Inc. (BIIB)
This section provides a comprehensive overview of the insiders with direct ownership of Biogen Inc. (BIIB). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
BIOGEN INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Michel Vounatsos
Chief Executive Officer |
61,233 | 25,785 | 67,261 $9.45 Million | 9 |
Feb 18, 2022
Reduced 3.92%
|
|
Susan H Alexander
EVP Chief Legal Officer |
43,643 | 43,950 | 36,265 $5.1 Million | 26 |
Feb 10, 2025
Reduced 2.18%
|
|
Caroline Dorsa
Director |
5,510 | 0 | 26,607 $3.74 Million | 4 |
Jun 21, 2024
Added 6.29%
|
|
Michael R Mcdonnell
EVP, Chief Financial Officer |
43,954 | 19,613 | 24,341 $3.42 Million | 22 |
Feb 10, 2025
Reduced 5.33%
|
|
Eric K Rowinsky
Director |
4,900 | 0 | 21,969 $3.09 Million | 5 |
Jun 21, 2024
Added 5.75%
|
|
Stephen A Sherwin
Director |
4,445 | 0 | 20,078 $2.82 Million | 4 |
Jun 21, 2024
Added 6.26%
|
|
Ginger Gregory
EVP, Human Resources |
34,107 | 21,584 | 17,598 $2.47 Million | 25 |
Feb 10, 2025
Reduced 3.48%
|
|
Alexander J Denner
Director |
2,145 | 0 | 15,099 $2.12 Million | 2 |
Jun 15, 2022
Added 8.32%
|
|
Richard Mulligan
Director |
2,145 | 0 | 15,099 $2.12 Million | 2 |
Jun 15, 2022
Added 8.32%
|
|
Nicole Murphy
Head of Pharm Ops and Tech |
18,941 | 6,399 | 14,055 $1.97 Million | 29 |
Feb 10, 2025
Reduced 4.55%
|
|
Nancy Leaming
Director |
775 | 0 | 13,763 $1.93 Million | 1 |
Jul 01, 2021
Added 5.33%
|
|
Christopher Viehbacher
President and CEO |
9,008 | 3,201 | 12,807 $1.8 Million | 2 |
Feb 07, 2025
Reduced 20.0%
|
|
Alfred Sandrock
Head of Research & Development |
8,182 | 12,682 | 10,169 $1.43 Million | 5 |
Jun 07, 2021
Reduced 43.0%
|
|
Stelios Papadopoulos
Director |
3,530 | 0 | 10,095 $1.42 Million | 2 |
Jun 15, 2022
Added 18.26%
|
|
Priya Singhal
Head of Development |
17,098 | 9,746 | 9,066 $1.27 Million | 40 |
Feb 10, 2025
Reduced 3.79%
|
|
Rachid Izzar
Head of Global Product Strat. |
19,487 | 6,936 | 8,553 $1.2 Million | 27 |
Feb 10, 2025
Reduced 4.95%
|
|
Brian S Posner
Director |
775 | 360 | 8,175 $1.15 Million | 2 |
Jul 01, 2021
Added 8.66%
|
|
Robin Kramer
Chief Accounting Officer |
11,219 | 3,734 | 8,011 $1.13 Million | 38 |
Feb 10, 2025
Reduced 2.97%
|
|
Jesus B Mantas
Director |
5,343 | 0 | 7,388 $1.04 Million | 5 |
Jun 21, 2024
Added 15.35%
|
|
Chirfi Guindo
Head of Glob Prod Strat & Com |
11,303 | 7,810 | 7,364 $1.03 Million | 10 |
Feb 18, 2022
Reduced 10.66%
|
|
William A Hawkins
Director |
4,445 | 0 | 6,490 $911,845 | 4 |
Jun 21, 2024
Added 17.11%
|
|
Alphonse Galdes
EVP Pharmaceutical Oper & Tech |
3,049 | 715 | 5,064 $711,492 | 4 |
Jan 19, 2022
Added 11.5%
|
|
Maria C Freire
Director |
4,445 | 0 | 4,445 $624,522 | 4 |
Jun 21, 2024
Added 23.16%
|
|
Susan Langer
Director |
2,300 | 0 | 2,759 $387,639 | 2 |
Jun 21, 2024
Added 32.69%
|
|
William D /Ca/ Jones
Director |
2,145 | 0 | 2,145 $301,372 | 2 |
Jun 15, 2022
Added 38.98%
|
|
Adam Keeney
Head of Corporate Development |
2,739 | 839 | 1,900 $266,950 | 4 |
Feb 07, 2025
Reduced 22.86%
|
|
Jane Grogan
Head of Research |
2,080 | 647 | 1,433 $201,336 | 4 |
Feb 07, 2025
Reduced 23.61%
|
|
Monish D Patolawala
Director |
1,340 | 0 | 1,340 $188,270 | 1 |
Jun 21, 2024
Added 50.0%
|